disease modifying antirheumatic drugs

disease modifying antirheumatic drugs (DMARD),

agents that apparently alter the course and progression of rheumatoid arthritis, as opposed to more rapidly acting substances that suppress inflammation and decrease pain, but do not prevent cartilage or bone erosion or progressive disability.